Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection Against Viral Pathogens
/PRNewswire/ -- Voltron Therapeutics, a Lucius Partners portfolio company, presented new evidence that demonstrates its VaxCelerate Vaccine platform's...
Source: prnewswire.com